Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Journal: Infection
Published: September 28, 2022
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Journal: The New England journal of medicine
Published: December 16, 2021
Evaluation of Neural Tube Defects (NTDs) After Exposure to Raltegravir During Pregnancy.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 26, 2019
Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data.
Journal: Pharmacoepidemiology and drug safety
Published: September 25, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026